This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Gareth Carpenter
15 Jun 2021

Trend Report - Sustainability in Pharma

While in the past, much of the discussion around sustainability in the pharmaceutical industry rightly focused on efforts to minimize the environmental impact of drug production, the needle has now shifted. There are signs that companies not only understand that it represents one of the world’s biggest challenges moving forward, but also that they are starting to incorporate sustainability practices into a much broader suite of operations.

The old argument that this highly regulated sector’s priority should be firmly on producing essential life-saving and life-changing medicines for patients and leave other much-more highly polluting industries to address the situation no longer holds sway. 

Using case studies and interviews with expert representatives from companies operating across the pharma value chain, this CPhI Trend Report, sponsored by Aspen API, investigates what the pharmaceutical industry is doing to establish and maintain credible sustainable strategies in several phases of the product lifecycle.

Mentioned Companies
Aspen Oss B.V
View company profile
Gareth Carpenter

Related News